Literature DB >> 24330004

Severe pertussis and hyperleukocytosis: is it time to change for exchange?

Amir Kuperman1, Yoav Hoffmann, Danny Glikman, Husein Dabbah, Zeev Zonis.   

Abstract

BACKGROUND: Pertussis is an important cause of infant death worldwide and continues to be a public health concern even in countries with high vaccination coverage. Severe (critical) pertussis with hyperleukocytosis is a severe form of the disease with up to 80% mortality rate. Attempts have been reported to reduce the white blood cell burden by exchange transfusion (ET) with conflicting conclusions. CASE REPORT: We report a case of critical pertussis in a neonate who was treated with ET, in view of a comprehensive literature review.
RESULTS: The patient was discharged without any sequelae.
CONCLUSION: ET should be considered in all infants suffering from critical pertussis and hyperleukocytosis, even in secondary care community hospitals.
© 2013 AABB.

Entities:  

Mesh:

Year:  2013        PMID: 24330004     DOI: 10.1111/trf.12519

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  9 in total

1.  Exchange transfusion for hemolytic hyperbilirubinemia: could some be averted by emergent administration of an inhibitor of bilirubin production?

Authors:  Susan E Wiedmeier; Timothy M Bahr; Robin K Ohls; Thomas R Christensen; Vickie L Baer; Sarah J Ilstrup; Kelly Cail; Robert D Christensen
Journal:  J Perinatol       Date:  2020-07-15       Impact factor: 2.521

Review 2.  Pertussis leukocytosis: mechanisms, clinical relevance and treatment.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2016-09-07       Impact factor: 3.166

Review 3.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 4.  Protecting Newborns Against Pertussis: Treatment and Prevention Strategies.

Authors:  Abdulbaset M Salim; Yan Liang; Paul E Kilgore
Journal:  Paediatr Drugs       Date:  2015-12       Impact factor: 3.022

5.  Malignant pertussis in infants: factors associated with mortality in a multicenter cohort study.

Authors:  Mathilde Coquaz-Garoudet; Dominique Ploin; Robin Pouyau; Yoav Hoffmann; Julien-Frederic Baleine; Benoît Boeuf; Hugues Patural; Anne Millet; Marc Labenne; Renaud Vialet; Didier Pinquier; Marie Cotillon; Jérôme Rambaud; Etienne Javouhey
Journal:  Ann Intensive Care       Date:  2021-05-07       Impact factor: 6.925

Review 6.  Fatal malignant pertussis with hyperleukocytosis in a Chinese infant: A case report and literature review.

Authors:  Shu-Feng Tian; Hong-Mei Wang; Ji-Kui Deng
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

7.  Severe Pertussis Infection With Hyperleukocytosis in a 10-Month-Old Unvaccinated Amish Female: A Case Report.

Authors:  Stephen Long; Robert B Lowe
Journal:  Cureus       Date:  2022-07-15

8.  Leukemoid Reaction in Infant Pertussis: Is There a Place for Hydroxyurea? A Case Report.

Authors:  Guillaume Maitre; Damien Schaffner; Julia Natterer; David Longchamp; Thomas Ferry; Manuel Diezi; Stefano Di Bernardo; Marie-Hélène Perez; Vivianne Amiet
Journal:  Front Pediatr       Date:  2018-09-26       Impact factor: 3.418

9.  Risk factors associated with death in infants <120 days old with severe pertussis: a case-control study.

Authors:  Cong Liu; Lin Yang; Yuwei Cheng; Hongmei Xu; Feng Xu
Journal:  BMC Infect Dis       Date:  2020-11-16       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.